About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Journal of NeuroImmune Pharmacology
›
Top Articles
Journal of NeuroImmune Pharmacology
5.7
(top 5%)
impact factor
1.0K
(top 20%)
papers
37.3K
(top 10%)
citations
91
(top 5%)
h
-index
5.8
(top 5%)
impact factor
1.1K
all documents
40.0K
doc citations
137
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain
Journal of NeuroImmune Pharmacology
2009
739
2
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Journal of NeuroImmune Pharmacology
2006
714
3
Microglia Biology in Health and Disease
Journal of NeuroImmune Pharmacology
2006
439
4
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
Journal of NeuroImmune Pharmacology
2020
391
5
Stress-Induced Immune Dysregulation: Implications for Wound Healing, Infectious Disease and Cancer
Journal of NeuroImmune Pharmacology
2006
311
6
Microglia in ALS: The Good, The Bad, and The Resting
Journal of NeuroImmune Pharmacology
2009
287
7
Central Mechanisms of Pain Revealed Through Functional and Structural MRI
Journal of NeuroImmune Pharmacology
2013
285
8
Tumor Necrosis Factor-alpha and the Roles it Plays in Homeostatic and Degenerative Processes Within the Central Nervous System
Journal of NeuroImmune Pharmacology
2012
284
9
Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
Journal of NeuroImmune Pharmacology
2014
267
10
CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease
Journal of NeuroImmune Pharmacology
2012
255
11
Opioid Drug Abuse and Modulation of Immune Function: Consequences in the Susceptibility to Opportunistic Infections
Journal of NeuroImmune Pharmacology
2011
254
12
Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis
Journal of NeuroImmune Pharmacology
2013
253
13
Manufactured Aluminum Oxide Nanoparticles Decrease Expression of Tight Junction Proteins in Brain Vasculature
Journal of NeuroImmune Pharmacology
2008
233
14
Up-regulation of BDNF in Astrocytes by TNF-α: A Case for the Neuroprotective Role of Cytokine
Journal of NeuroImmune Pharmacology
2006
225
15
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain
Journal of NeuroImmune Pharmacology
2013
225
16
Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System
Journal of NeuroImmune Pharmacology
2006
222
17
Epstein–Barr Virus Infection and Multiple Sclerosis: A Review
Journal of NeuroImmune Pharmacology
2010
221
18
HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities
Journal of NeuroImmune Pharmacology
2010
206
19
Methamphetamine-Associated Psychosis
Journal of NeuroImmune Pharmacology
2012
202
20
Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration
Journal of NeuroImmune Pharmacology
2014
202
21
Novel Nanomaterials for Clinical Neuroscience
Journal of NeuroImmune Pharmacology
2008
199
22
Divergent Roles for Tumor Necrosis Factor-α in the Brain
Journal of NeuroImmune Pharmacology
2007
196
23
Current Views on the Roles of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
Journal of NeuroImmune Pharmacology
2010
195
24
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
Journal of NeuroImmune Pharmacology
2013
191
25
Neurodegeneration and Ageing in the HAART Era
Journal of NeuroImmune Pharmacology
2009
182
26
Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels
Journal of NeuroImmune Pharmacology
2010
182
27
Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients
Journal of NeuroImmune Pharmacology
2009
179
28
Curcumin Ameliorates the Neurodegenerative Pathology in A53T α-synuclein Cell Model of Parkinson’s Disease Through the Downregulation of mTOR/p70S6K Signaling and the Recovery of Macroautophagy
Journal of NeuroImmune Pharmacology
2013
175
29
CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease?
Journal of NeuroImmune Pharmacology
2009
174
30
Life and Death of Microglia
Journal of NeuroImmune Pharmacology
2009
173
31
CNS Inflammation and Macrophage/Microglial Biology Associated with HIV-1 Infection
Journal of NeuroImmune Pharmacology
2009
170
32
Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders
Journal of NeuroImmune Pharmacology
2013
167
33
Wnt Signaling: Role in Alzheimer Disease and Schizophrenia
Journal of NeuroImmune Pharmacology
2012
165
34
Immune Players in the CNS: The Astrocyte
Journal of NeuroImmune Pharmacology
2013
165
35
Circulating Cytokines as Biomarkers of Alcohol Abuse and Alcoholism
Journal of NeuroImmune Pharmacology
2010
161
36
Roles of Activated Microglia in Hypoxia Induced Neuroinflammation in the Developing Brain and the Retina
Journal of NeuroImmune Pharmacology
2013
160
37
Multiple Sclerosis and T Lymphocytes: An Entangled Story
Journal of NeuroImmune Pharmacology
2015
160
38
MDR- and CYP3A4-Mediated Drug–Drug Interactions
Journal of NeuroImmune Pharmacology
2006
159
39
Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation
Journal of NeuroImmune Pharmacology
2015
154
40
Cannabis Addiction and the Brain: a Review
Journal of NeuroImmune Pharmacology
2018
154
41
Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease
Journal of NeuroImmune Pharmacology
2020
149
42
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials
Journal of NeuroImmune Pharmacology
2015
148
43
A Transient Decrease in Spleen Size Following Stroke Corresponds to Splenocyte Release into Systemic Circulation
Journal of NeuroImmune Pharmacology
2012
147
44
Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells
Journal of NeuroImmune Pharmacology
2006
146
45
Melatonin Rescue Oxidative Stress-Mediated Neuroinflammation/ Neurodegeneration and Memory Impairment in Scopolamine-Induced Amnesia Mice Model
Journal of NeuroImmune Pharmacology
2019
146
46
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
Journal of NeuroImmune Pharmacology
2013
145
47
Microglial Phenotype and Adaptation
Journal of NeuroImmune Pharmacology
2013
144
48
Modulation of Immune Function by Morphine: Implications for Susceptibility to Infection
Journal of NeuroImmune Pharmacology
2006
142
49
Toll-like Receptors in Defense and Damage of the Central Nervous System
Journal of NeuroImmune Pharmacology
2007
141
50
Imaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease
Journal of NeuroImmune Pharmacology
2009
141
site/software ©
exaly
; All materials licenced under
CC by-SA
.